Vazegepant hydrochloride, CAS [[1414976-20-7]]

Produktübersicht

• Artikelname: Vazegepant hydrochloride, CAS [[1414976-20-7]]
• Artikelnummer: BYT-ORB1298717
• Hersteller Artikelnummer: orb1298717
• Alternativnummer: BYT-ORB1298717-1, BYT-ORB1298717-1, BYT-ORB1298717-10, BYT-ORB1298717-100, BYT-ORB1298717-25, BYT-ORB1298717-5, BYT-ORB1298717-50
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: CGRP Receptor, CGRP, CGRPReceptor, COVID-19, BHV 3500, BHV3500, BHV-3500, Calcitonin gene-related peptide receptor, Inhibitor, gepant, inflammation, intranasal, inhibit, migraine, receptor, Zavegepant, soluble, Vazegepant, Vazegepant HCl, Vazegepant hydrochloride, Vazegepant Hydrochloride

Produktbeschreibung

Vazegepant hydrochloride is a novel intranasal CGRP receptor antagonist for the acute treatment of migraine, supported by positive Phase II/III clinical data. It is utilized in preclinical research to investigate CGRP-mediated pathways in both in vitro binding assays and in vivo models of migraine and pain.

Produkteigenschaften

• Molekulargewicht: 675.3
• Reinheit: 99.56% (May vary between batches)
• CAS Nummer: [1414976-20-7]
• Formel: C36H47ClN8O3
• Target-Kategorie: CGRP Receptor

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:30 mg/mL (44.42 mM)